Literature DB >> 15743783

Oncostatin M inhibits proliferation of rat oval cells, OC15-5, inducing differentiation into hepatocytes.

Atsuhito Okaya1, Junichi Kitanaka, Nobue Kitanaka, Makoto Satake, Yuna Kim, Kunihiko Terada, Toshihiro Sugiyama, Motohiko Takemura, Jiro Fujimoto, Nobuyuki Terada, Atsushi Miyajima, Tohru Tsujimura.   

Abstract

Oval cells of the liver participate in liver regeneration when hepatocytes are prevented from proliferating in response to liver damage. To clarify the role of oncostatin M (OSM) in the liver regeneration involving oval cells, we examined the expression of OSM and OSM-specific receptor (OSM-R) in the liver undergoing regeneration in the 2-acetylaminofluorene/partial hepatectomy model. Expression levels of OSM-R changed in correlation to the number of oval cells, and its expression was exclusively observed in oval cells. On the other hand, OSM was expressed in both oval cells and Kupffer cells. To examine the effect of OSM on the growth and differentiation of oval cells, rat oval cells (OC15-5) were incubated in conditioned medium of 293T cells expressing rat OSM cDNA. This resulted in suppression of growth, changes in morphology (microvilli and large cytoplasm with developed organelles), and expression of hepatocyte markers (albumin, tyrosine amino transferase, and tryptophan oxygenase). The effects of the conditioned medium with rat OSM were abrogated by introducing a small interfering RNA specifically targeting rat OSM-R into OC15-5 cells. These results indicate that OSM is a key mediator for inducing differentiation of OC15-5 cells into hepatocytes and suggest that the OSM/OSM-R system is pivotal in the differentiation of oval cells into hepatocytes, thereby promoting liver regeneration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15743783      PMCID: PMC1602354          DOI: 10.1016/S0002-9440(10)62292-4

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  30 in total

Review 1.  Hepatic oval 'stem' cell in liver regeneration.

Authors:  Seh Hoon Oh; Heather M Hatch; Bryon E Petersen
Journal:  Semin Cell Dev Biol       Date:  2002-12       Impact factor: 7.727

2.  Similarities in the sequence of early histological changes induced in the liver of the rat by ethionine, 2-acetylamino-fluorene, and 3'-methyl-4-dimethylaminoazobenzene.

Authors:  E FARBER
Journal:  Cancer Res       Date:  1956-02       Impact factor: 12.701

Review 3.  Hepatic stem cells: from inside and outside the liver?

Authors:  M R Alison; P Vig; F Russo; B W Bigger; E Amofah; M Themis; S Forbes
Journal:  Cell Prolif       Date:  2004-02       Impact factor: 6.831

4.  Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer.

Authors:  A Kamiya; T Kinoshita; Y Ito; T Matsui; Y Morikawa; E Senba; K Nakashima; T Taga; K Yoshida; T Kishimoto; A Miyajima
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

Review 5.  Liver regeneration.

Authors:  C J Steer
Journal:  FASEB J       Date:  1995-11       Impact factor: 5.191

6.  Role of c-kit receptor tyrosine kinase in development of oval cells in the rat 2-acetylaminofluorene/partial hepatectomy model.

Authors:  S Matsusaka; T Tsujimura; A Toyosaka; K Nakasho; A Sugihara; E Okamoto; K Uematsu; N Terada
Journal:  Hepatology       Date:  1999-03       Impact factor: 17.425

7.  Isolation of oval cells from Long-Evans Cinnamon rats and their transformation into hepatocytes in vivo in the rat liver.

Authors:  O Yasui; N Miura; K Terada; Y Kawarada; K Koyama; T Sugiyama
Journal:  Hepatology       Date:  1997-02       Impact factor: 17.425

8.  Maturation of fetal hepatocytes in vitro by extracellular matrices and oncostatin M: induction of tryptophan oxygenase.

Authors:  Akihide Kamiya; Nobuhiko Kojima; Taisei Kinoshita; Yasuyuki Sakai; Atsushi Miyaijma
Journal:  Hepatology       Date:  2002-06       Impact factor: 17.425

9.  Hepatocyte proliferation and tissue remodeling is impaired after liver injury in oncostatin M receptor knockout mice.

Authors:  Koji Nakamura; Hidenori Nonaka; Hiroki Saito; Minoru Tanaka; Atsushi Miyajima
Journal:  Hepatology       Date:  2004-03       Impact factor: 17.425

10.  Mouse oncostatin M: an immediate early gene induced by multiple cytokines through the JAK-STAT5 pathway.

Authors:  A Yoshimura; M Ichihara; I Kinjyo; M Moriyama; N G Copeland; D J Gilbert; N A Jenkins; T Hara; A Miyajima
Journal:  EMBO J       Date:  1996-03-01       Impact factor: 11.598

View more
  16 in total

1.  Model systems and clinical applications of hepatic stem cells for liver regeneration.

Authors:  Min Zhang; Yan Zhong; Jun Chen
Journal:  Hepatol Int       Date:  2011-12-21       Impact factor: 6.047

2.  Early differential expression of oncostatin M in obstructive nephropathy.

Authors:  Wafa M Elbjeirami; Luan D Truong; Ahmad Tawil; Wansheng Wang; Sara Dawson; Hui Y Lan; Ping Zhang; Gabriela E Garcia; C Wayne Smith
Journal:  J Interferon Cytokine Res       Date:  2010-07       Impact factor: 2.607

3.  Isolation, characterization and culture of Thy1-positive cells from fetal rat livers.

Authors:  Zvibel Isabel; Bronstein Miri; Hubel Einav; Bar-Lev Ella; Halpern Zamir; Oren Ran
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

4.  Lack of glycoprotein 130/signal transducer and activator of transcription 3-mediated signaling in hepatocytes enhances chronic liver injury and fibrosis progression in a model of sclerosing cholangitis.

Authors:  Werner Plum; Darjus F Tschaharganeh; Daniela C Kroy; Eva Corsten; Stephanie Erschfeld; Uta Dierssen; Hermann Wasmuth; Christian Trautwein; Konrad L Streetz
Journal:  Am J Pathol       Date:  2010-04-09       Impact factor: 4.307

5.  Liver epithelioid progenitor cells derived from fetal Luxi bovine alleviate liver fibrosis.

Authors:  Kunfu Wang; Hao Liu; Jinjuan Yang; Caiyun Ma; Zebiao Zhang; Dong Zheng; Weijun Guan
Journal:  Cytotechnology       Date:  2017-06-17       Impact factor: 2.058

6.  Loss of Oncostatin M Signaling in Adipocytes Induces Insulin Resistance and Adipose Tissue Inflammation in Vivo.

Authors:  Carrie M Elks; Peng Zhao; Ryan W Grant; Hardy Hang; Jennifer L Bailey; David H Burk; Margaret A McNulty; Randall L Mynatt; Jacqueline M Stephens
Journal:  J Biol Chem       Date:  2016-06-20       Impact factor: 5.157

7.  Effect of oncostatin M on uridine diphosphate-5'-glucuronosyltransferase 1A1 through cross talk with constitutive androstane receptor.

Authors:  Hisashi Masuyama; Hideki Nakatsukasa; Yuji Hiramatsu
Journal:  Mol Endocrinol       Date:  2010-03-02

8.  Oncostatin m is produced in adipose tissue and is regulated in conditions of obesity and type 2 diabetes.

Authors:  David Sanchez-Infantes; Ursula A White; Carrie M Elks; Ron F Morrison; Jeffrey M Gimble; Robert V Considine; Anthony W Ferrante; Eric Ravussin; Jacqueline M Stephens
Journal:  J Clin Endocrinol Metab       Date:  2013-12-02       Impact factor: 5.958

9.  Oncostatin M gene therapy attenuates liver damage induced by dimethylnitrosamine in rats.

Authors:  Tetsuhiro Hamada; Ayuko Sato; Tadamichi Hirano; Takashi Yamamoto; Gakuhei Son; Masayuki Onodera; Ikuko Torii; Takashi Nishigami; Minoru Tanaka; Atsushi Miyajima; Shuhei Nishiguchi; Jiro Fujimoto; Tohru Tsujimura
Journal:  Am J Pathol       Date:  2007-07-19       Impact factor: 4.307

10.  Phenotype reversion in fetal human liver epithelial cells identifies the role of an intermediate meso-endodermal stage before hepatic maturation.

Authors:  Mari Inada; Antonia Follenzi; Kang Cheng; Manju Surana; Brigid Joseph; Daniel Benten; Sriram Bandi; Hong Qian; Sanjeev Gupta
Journal:  J Cell Sci       Date:  2008-03-04       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.